EP Patent

EP4685237A1 — Process and intermediates for the preparation of etrasimod and related compounds

Assigned to Curia Spain SA · Expires 2026-01-28 · 0y expired

What this patent protects

The present invention relates to an efficient and industrially applicable process and intermediates for the preparation of etrasimod and related compounds.

USPTO Abstract

The present invention relates to an efficient and industrially applicable process and intermediates for the preparation of etrasimod and related compounds.

Drugs covered by this patent

Patent Metadata

Patent number
EP4685237A1
Jurisdiction
EP
Classification
—
Expires
2026-01-28
Drug substance claim
No
Drug product claim
No
Assignee
Curia Spain SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.